This vitally important expose shows how the Bush administration has systematically misled Americans on a wide range of scientific issues affecting public health, foreign policy, and the environment by ignoring, suppressing, manipulating, or even distorting scientific research. It is the first book to focus exclusively on how this explosive issue has played out during the presidency of George W. Bush and the first to comprehensively document his administration's abuses of science. This paperback edition contains a new preface bringing to light the most up-to-date research on these abuses.
"Undermining Science" covers:
* The Bush administration's abuse and misuse of science in areas including stem cell research, AIDS prevention, environmental protection, the Iraq war, the teaching of evolution, and global warming;
* The administration's use of political litmus tests in selecting administrators for science-based agencies and in selecting scientists on federal advisory committees;
* The dangerous consequences of the Bush administration's war on science for the caliber and integrity of the nation's scientific research.

"Innovation Policy and the Economy" provides an ongoing forum for the presentation of research on the interactions among public policy, the innovation process, and the economy. Papers in this volume include a consideration of the complex set of innovation policy challenges that arise in managing publicly funded research, an examination of the increasingly visible role of philanthropic funding for science, a look at the increasingly contentious issue of public funding of growth-oriented entrepreneurship, and two papers that turn their attention to the evaluation of recent federal policy changes as the result of the America Invents Act and the America Competes Act.

The scientific advances that underpin economic growth and human health would not be possible without research investments. Yet demonstrating the impact of research programs is a challenge, especially in areas that span disciplines, industrial sectors, and encompass both public and private sector activity. All areas of research are under pressure to demonstrate benefits from federal funding of research. This exciting and innovative study demonstrates new methods and tools to trace the impact of federal research funding on the structure of research, and the subsequent economic activities of funded researchers. The case study is food safety research, which is critical to avoiding outbreaks of disease. The authors make use of an extraordinary new data infrastructure and apply new techniques in text analysis. Focusing on the impact of US federal food safety research, this book develops vital data-intensive methodologies that have a real world application to many other scientific fields.

A proposal for using cost-benefit analysis to evaluate the socioeconomic impact of public investment in large scientific projects. Large particle accelerators, outer space probes, genomics platforms: all are scientific enterprises managed through the new form of the research infrastructure, in which communities of scientists collaborate across nations, universities, research institutions, and disciplines. Such large projects are often publicly funded, with no accepted way to measure the benefits to society of these investments. In this book, Massimo Florio suggests the use of cost-benefit analysis (CBA) to evaluate the socioeconomic impact of public investment in large and costly scientific projects. The core concept of CBA of any infrastructure is to undertake the consistent intertemporal accounting of social welfare effects using the available information. Florio develops a simple framework for such accounting in the research infrastructure context and then offers a systematic analysis of the benefits in terms of the social agents involved. He measures the benefits to scientists, students, and postdoctoral researchers; the effect on firms of knowledge spillovers; the benefits to users of information technology and science-based innovation; the welfare effects on the general public of cultural services provided by RIs; and the willingness of taxpayers to fund scientific knowledge creation. Finally, Florio shows how these costs and benefits can be expressed in the form of stochastic net present value and other summary indicators.

An "other transaction" (OT) is a special vehicle used by federal agencies for obtaining or advancing research and development (R&D) or prototypes. An OT is not a contract, grant or co-operative agreement, and there is no statutory or regulatory definition of "other transaction". Only those agencies that have been provided OT authority may engage in other transaction. Generally, the reason for OT authority is that the government needs to obtain leading edge R&D and prototypes from commercial sources, but some companies are unwilling or unable to comply with the government's procurement regulations. This book examines the "other transaction authority" and its uses by the federal agencies.

On August 2, 2007, Congress passed the America COMPETES Act (H.R. 2272), which the President signed into law (P.L. 110-69) on August 9, 2007. The act responds to concerns that the United States may not be able to compete economically with other nations in the future due to insufficient investment today in science and technology research and science, technology, engineering, and mathematics (STEM) education and workforce development. A similar concern had led President Bush to announce the American Competitiveness Initiative (ACI) in January 2006 during his State of the Union address. The America COMPETES Act authorises an increase in the nation's investment in science and engineering research and in STEM education from kindergarten to graduate school and postdoctoral education. The act also establishes the Advanced Research Projects Agency-Energy (ARPA-E) and Discovery Science and Engineering Innovation Institutes. (Appendix A provides a summary of the act's programs.) The act authorises increases in funding for the National Science Foundation (NSF), National Institute of Standards and Technology (NIST) laboratories, and the Department of Energy (DOE) Office of Science over FY2008-FY2010. If maintained, the increases would double the budgets of those agencies over seven years. The Administration's ACI also proposes a doubling-path, but for over ten years for physical sciences and engineering research at the three agencies. Within DOE, ARPA-E is designed to support transformational energy technology research projects with the goal of enhancing the economic and energy security of the United States, based on the Defense Advanced Research Projects Agency (DARPA). The Administration and others support the conceptual goal of ARPA-E, but questions whether or not the DARPA model can be used for the energy sector, and has concerns about it potentially redirecting funds from current DOE research activities. ARPA-E proponents counter that ARPA-E is needed to facilitate the energy marketplace by accelerating research that will bridge the gap between basic research and industrial development. At the heart of the America COMPETES Act is the goal of maintaining the United States as the leader in the global economy. Three broad trends influence today's globalisation of the economy. The first is technology, which has sharply reduced the cost of communication and transportation that previously divided markets. The second is a dramatic increase in the world supply of labour producing goods and services traded internationally. The third is government policies that have reduced barriers to trade and investment.

Modern science is big business. Governments, universities, and corporations have invested billions of dollars in scientific and technological research in the hope of obtaining power and profit. For the most part, this investment has benefited science and society, leading to new discoveries, inventions, disciplines, specialties, jobs, and career opportunities. However, there is a dark side to the influx of money into science. Unbridled pursuit of financial gain in science can undermine scientific norms, such as objectivity, honesty, openness, respect for research participants, and social responsibility.
In The Price of Truth, David B. Resnik examines some of the important and difficult questions resulting from the financial and economic aspects of modern science. How does money affect scientific research? Have scientists become entrepreneurs bent on making money instead of investigators searching for the truth? How does the commercialization of research affect the public's perception of science? Can scientists prevent money from corrupting the research enterprise? What types of rules, polices, and guidelines should scientists adopt to prevent financial interests from adversely affecting research and the public's opinion of science?

During the latter half of the twentieth century, federal funding in the United States for scientific research and development increased dramatically. Yet, despite the infusion of public funds into research centers, the relationship between public policy and research and development remains poorly understood. How does the federal government attempt to harness scientific knowledge and resources for the nation's economic welfare and competitiveness in the global marketplace? Who makes decisions about controversial scientific experiments, such as genetic engineering and space exploration? Who is held accountable when things go wrong? In this lucidly-written introduction to the topic, Sylvia Kraemer draws upon her extensive experience in government to develop a useful and powerful framework for thinking about the American approach to shaping and managing scientific innovation. Kraemer suggests that the history of science, technology, and politics is best understood as a negotiation of ongoing tensions between open and closed systems. Open systems depend on universal access to information that is complete, verifiable, and appropriately used. Closed systems, in contrast, are composed of unique and often proprietary features, which are designed to control usage. From the Constitution's patent clause to current debates over intellectual property, stem cells, and Internet regulation, Kraemer shows the promise - as well as the limits - of open systems in advancing scientific progress, as well as the nation's economic vitality.

A leading scholar of the history and philosophy of economic thought, Philip Mirowski argues that there has been a top-to-bottom transformation in how scientific research is organized and funded in Western countries over the past two decades and that these changes necessitate a reexamination of the ways that science and economics interact. Mirowski insists on the need to bring together the insights of economics, science studies, and the philosophy of science in order to understand how and why particular research programs get stabilized through interdisciplinary appropriation, controlled attributions of error, and funding restrictions. Mirowski contends that neoclassical economists have persistently presumed and advanced an "effortless economy of science," a misleading model of a self-sufficient and conceptually self-referential social structure that transcends market operations in pursuit of absolute truth. In the stunning essays collected here, he presents a radical critique of the ways that neoclassical economics is used to support, explain, and legitimate the current social practices underlying the funding and selection of "successful" science projects. He questions a host of theories, including the portraits of science put forth by Karl Popper, Michael Polanyi, and Thomas Kuhn. Among the many topics he examines are the social stabilization of quantitative measurement, the repressed history of econometrics, and the social construction of the laws of supply and demand and their putative opposite, the gift economy. In The Effortless Economy of Science? Mirowski moves beyond grand abstractions about science, truth, and democracy in order to begin to talk about the way science is lived and practiced today.

In the nineteenth century, scientific practice underwent a dramatic transformation from personal endeavor to business enterprise. In Spectrum of Belief, Myles Jackson explores this transformation through a sociocultural history of the rise of precision optics in Germany. He uses the career of the optician Joseph von Fraunhofer (1787-1826) to probe the relationship between science and society, and between artisans and experimental natural philosophers, during this important transition. Fraunhofer came from a long line of glassmakers. Orphaned at age eleven, the young apprentice moved in with his master, the court decorative glass cutter. At age nineteen, bored with his work and angered by his master's refusal to allow him to study optical theory, Fraunhofer took a position at the Optical Institute assisting in the manufacture of achromatic lenses. Within ten years he was producing the world's finest achromatic lenses and prisms. Housed in an old Benedictine monastery, Fraunhofer's laboratory mirrored the labor of the monks. Because of his secrecy (after his death, even those who had worked most closely with him could not achieve his success), British experimental natural philosophers were unable to reproduce his work. This secrecy, while guaranteeing his institute's monopoly, thwarted Fraunhofer's attempts to gain credibility within the scientific community, which looked down on artisanal work and its clandestine practices as an affront. The response to the ensuing rise of German optical technology sheds light on crucial social, economic, and political issues of the period, such as mechanization, patent law reform, the role of skills in both physics and society, the rise of Mechanics' Institutes, and scientific patronage. After his death, Fraunhofer's example was used in the newly united Germany to argue for the merging of scientific research and technological innovation with industrial and state support.

This book had its genesis in Dr. Davis' remarkable editorial in the "New England Journal of Medicine" that sharply criticized medical schools for lowering their standards of admission to fill minority quotas and ultimately risking the lives of patients. Davis' position (widely held, but seldom articulated) is that the standard of medical care is an even higher ideal than the redress of past racial injustice. A passionate battle is now being fought in our universities over the freedom to pursue ideals of objectivity and intellectual freedom that are incompatible with the mandates of a pragmatic social policy."Storm Over Biology" examines many of the areas where scientific and social interests intersect and often conflict, such as genetic engineering and sociobiology. The essays are grouped under six headings: genetics, racism and affirmative action; objectivity and science; evolution - sociobiology, ethics, and molecular genetics; medical education and affirmative action; public concern over science; and genetic engineering.

'A virtuoso feat ... a book of panoramic breadth' New York Times Book Review 'A devastating analysis ... Wright is a master of knitting together complex narratives' The Observer Just as Lawrence Wright's The Looming Tower became the defining account of our century's first devastating event, 9/11, so The Plague Year will become the defining account of the second. The story starts with the initial moments of Covid's appearance in Wuhan and ends with Joseph Biden's inauguration in an America ravaged by well over 400,000 deaths - a mortality already some ten times worse than US combat deaths in the entire Vietnam War. This is an anguished, furious memorial to a year in which all of America's great strengths - its scientific knowledge, its great civic and intellectual institutions, its spirit of voluntarism and community - were brought low, not by a terrifying new illness alone, but by political incompetence and cynicism on a scale for which there has been no precedent. With insight, sympathy, clarity and rage, The Plague Year allows the reader to see the unfolding of this great tragedy, talking with individuals on the front line, bringing together many moving and surprising stories and painting a devastating picture of a country literally and fatally misled. 'Maddening and sobering - as comprehensive an account of the first year of the pandemic as we've yet seen' Kirkus

This book investigates the governance structures and mechanisms of knowledge and technology transfer in the context of innovation and production systems in six regions of Europe. For that purpose, the author develops a new and innovative heuristic governance model of knowledge transfer systems. Against the assumption of far-reaching institutional coherence and homogeneity of national systems in existing scholarship, Michael Ortiz demonstrates that national innovation and production systems are regionally variegated. With analyses of strengths and weaknesses, barriers, shortcomings, and dilemmas of regional innovation and knowledge transfer systems, the book ultimately identifies best practice models and policy recommendations for the investigated regions.

On 28 April 2021, the Indonesian government, under President Joko Widodo, dissolved the Ministry of Research, Technology, and Higher Education (Kemenristek-Dikti). Since then, the management of higher education has been taken over by the Ministry of Education and Culture, while research and innovation are now the responsibility of the National Research and Innovation Agency (Badan Riset dan Inovasi Nasional, or BRIN). Based on Presidential Regulation (Perpres) Nos. 33 and 78 of 2021, various research institutes, such as LIPI, BATAN, LAPAN and BPPT, and research agencies in some ministries have been or will be merged into BRIN, making it a "super-government agency" with an "overarching" role. With a Rp26 trillion budget allocated by the government for research per year and with a large number of researchers, BRIN is expected to boost national research and innovation, and help the country catch up with countries such as Singapore and South Korea.

How do scientists impact society in the twenty-first century? Many scientists are increasingly interested in the impact that their research will have on the public. Scientists likewise must answer the question above when applying for funding from government agencies, particularly as part of the 'Broader Impacts' criterion of proposals to the US National Science Foundation. This book equips scientists in all disciplines to do just that, by providing an overview of the origins, history, rationale, examples, and case studies of broader impacts, primarily drawn from the author's experiences over the past five decades. Beyond including theory and evidence, it serves as a 'how to' guide for best practices for scientists. Although this book primarily uses examples from the NSF, the themes and best practices are applicable to scientists and applications around the world where funding also requires impacts and activities that benefit society.

Commercial and academic communities use private rules to regulate everything from labor conditions to biological weapons. This self-governance is vital in the twenty-first century, where private science and technology networks cross so many borders that traditional regulation and treaty solutions are often impractical. Self-Governance in Science analyzes the history of private regulation, identifies the specific market factors that make private standards stable and enforceable, explains what governments can do to encourage responsible self-regulation, and asks when private power might be legitimate. Unlike previous books which stress sociology or political science perspectives, Maurer emphasizes the economic roots of private power to deliver a coherent and comprehensive account of recent scholarship. Individual chapters present a detailed history of past self-government initiatives, describe the economics and politics of private power, and extract detailed lessons for law, legitimacy theory, and public policy.

An in-depth analysis of why COVID-19 warnings failed and how to avert the next disaster Epidemiologists and national security agencies warned for years about the potential for a deadly pandemic, but in the end global surveillance and warning systems were not enough to avert the COVID-19 disaster. In The COVID-19 Intelligence Failure, Erik J. Dahl demonstrates that understanding how intelligence warnings work-and how they fail-shows why the years of predictions were not enough. In the first in-depth analysis of the topic, Dahl examines the roles that both traditional intelligence services and medical intelligence and surveillance systems play in providing advance warning against public health threats-and how these systems must be improved for the future. For intelligence to effectively mitigate threats, specific, tactical-level warnings must be collected and shared in real time with receptive decision makers who will take appropriate action. Dahl shows how a combination of late and insufficient warnings about COVID-19, the Trump administration's political aversion to scientific advice, and decentralized public health systems all exacerbated the pandemic in the United States. Dahl's analysis draws parallels to other warning failures that preceded major catastrophes from Pearl Harbor to 9/11, placing current events in context. The COVID-19 Intelligence Failure is a wake-up call for the United States and the international community to improve their national security, medical, and public health intelligence systems and capabilities.

In recent years the news media have been awash in stories about increasingly close ties between college campuses and multimillion-dollar corporations. Our nation's universities, the story goes, reap enormous windfalls patenting products of scientific research that have been primarily funded by taxpayers. Meanwhile, hoping for new streams of revenue from their innovations, the same universities are allowing their research--and their very principles--to become compromised by quests for profit. But is that really the case? Is money really hopelessly corrupting science?
With "Science for Sale," acclaimed journalist Daniel S. Greenberg reveals that campus capitalism is more complicated--and less profitable--than media reports would suggest. While universities seek out corporate funding, news stories rarely note that those industry dollars are dwarfed by government support and other funds. Also, while many universities have set up technology transfer offices to pursue profits through patents, many of those offices have been financial busts. Meanwhile, science is showing signs of providing its own solutions, as highly publicized misdeeds in pursuit of profits have provoked promising countermeasures within the field.
But just because the threat is overhyped, Greenberg argues, doesn't mean that there's no danger. From research that has shifted overseas so corporations can avoid regulations to conflicts of interest in scientific publishing, the temptations of money will always be a threat, and they can only be countered through the vigilance of scientists, the press, and the public.
Based on extensive, candid interviews with scientists and administrators, "Science for Sale "will beindispensable to anyone who cares about the future of scientific research.

How the US Environmental Protection Agency designed the governance of risk and forged its legitimacy over the course of four decades. The US Environmental Protection Agency was established in 1970 to protect the public health and environment, administering and enforcing a range of statutes and programs. Over four decades, the EPA has been a risk bureaucracy, formalizing many of the methods of the scientific governance of risk, from quantitative risk assessment to risk ranking. Demortain traces the creation of these methods for the governance of risk, the controversies to which they responded, and the controversies that they aroused in turn. He discusses the professional networks in which they were conceived; how they were used; and how they served to legitimize the EPA. Demortain argues that the EPA is structurally embedded in controversy, resulting in constant reevaluation of its credibility and fueling the evolution of the knowledge and technologies it uses to produce decisions and to create a legitimate image of how and why it acts on the environment. He describes the emergence and institutionalization of the risk assessment-risk management framework codified in the National Research Council's Red Book, and its subsequent unraveling as the agency's mission evolved toward environmental justice, ecological restoration, and sustainability, and as controversies over determining risk gained vigor in the 1990s. Through its rise and fall at the EPA, risk decision-making enshrines the science of a bureaucracy that learns how to make credible decisions and to reform itself, amid constant conflicts about the environment, risk, and its own legitimacy.

"Limited by Design" is the first comprehensive study of the varying roles played by the more than 16,000 research and development laboratories in the U.S. national innovation system. Michael Crow and Barry Bozeman offer policy makers and scientists a blueprint for making more informed decisions about how to best utilize and develop the capabilities of these facilities. Some labs, such as Bell Labs, Westinghouse, and Eastman Kodak, have been global players since the turn of the century. Others, such as Los Alamos National Laboratory, have been mainstays of the military/energy industrial complex since they evolved in the 1940s. These and other institutions have come to serve as the infrastructure upon which a range of industries have relied and have had a tremendous impact on U.S. social and economic history.

Michael Crow and Barry Bozeman illustrate the histories, missions, structure, and behavior of individual laboratories, and explore the policy contexts in which they are embedded. In studying this large and varied collection of labs, Crow, Bozeman, and their colleagues develop a new framework for understanding the structure and behavior of laboratories that also provides a basis for rationalizing federal science and technology policy to create more effective laboratories.

The book draws upon interviews and surveys collected from thousands of scientists, administrators, and policy makers, and features boxed "lab windows" throughout that provide detailed information on the variety of laboratories active in the U.S. national innovation system.

"Limited by Design" addresses a range of questions in order to enable policy makers, university administrators, and scientists to plan effectively for the future of research and development.